Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong · Delayed Price · Currency is HKD 43.36
+0.84 (1.98%)
At close: Dec 11, 2025
HKG:3692 Market Cap
HKG:3692 has a market cap or net worth of 257.41 billion as of December 11, 2025. Its market cap has increased by 152.78% in one year.
Market Cap
257.41B
Enterprise Value
227.82B
Revenue
14.45B
Ranking
n/a
PE Ratio
48.32
Stock Price
43.36
Market Cap Chart
Since June 14, 2019, HKG:3692's market cap has increased from 111.27B to 257.41B, an increase of 131.35%. That is a compound annual growth rate of 13.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 257.41B | 151.02% |
| Dec 31, 2024 | 102.55B | 9.84% |
| Dec 29, 2023 | 93.36B | 6.25% |
| Dec 30, 2022 | 87.86B | -21.92% |
| Dec 31, 2021 | 112.52B | -49.44% |
| Dec 31, 2020 | 222.55B | 48.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 281.07B |
| JD Health International | 192.73B |
| Innovent Biologics | 146.70B |
| WuXi Biologics | 138.19B |
| Sino Biopharmaceutical | 121.20B |
| Akeso | 114.59B |
| Sichuan Kelun-Biotech Biopharmaceutical | 99.48B |
| Alibaba Health Information Technology | 86.48B |